inhaled treprostinil solution hemodynamic studies showed that duration and degree of pulmonary vascular resistance reduction were dose-dependent 7,8 and a recent real-world analysis that used specialty pharmacy data of patients receiving inhaled treprostinil, showed higher survival rates and longer time to transition to parenteral therapy in patients who were receiving higher inhaled treprostinil doses. 9